Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

animal health

This page shows the latest animal health news and features for those working in and with pharma, biotech and healthcare.

European MPs call for urgent action against antimicrobial resistance

European MPs call for urgent action against antimicrobial resistance

to discuss the development of new antibiotics and initiatives by national health authorities to fight AMR. ... These actions should be fully integrated into One Health Strategies providing solutions for human, animal and environmental health.

Latest news

More from news
Approximately 13 fully matching, plus 107 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    The Bernstein analyst, Wimal Kapada, suggested recently that Bayer’s animal health division could be for sale or be spun out. ... So two opportunities here – acquisition of animal health products and out-licensing to Bayer’s pharma business.

  • Deal Watch February 2017 Deal Watch February 2017

    There were six deals worth more than $1bn this month: three focused on medtech, two on ethical pharmaceuticals and one in nutrition/ consumer health. ... animal health business (Merial) for Boehringer Ingelheim's consumer healthcare business.

  • Deal Watch October 2016 Deal Watch October 2016

    For Lilly this is a good deal as it acquired the Novartis Animal Health business for $4.5bn last year and Elanco, its animal health business, is now said to be ... one of the top three animal health companies.

  • Deal Watch May 2016 Deal Watch May 2016

    It is thought that Bayer can run to as much as $140 per share and rumours are abounding about a sale of its animal health interests to support the acquisition. ... This would be in line with the long standing advice of build up or exit for Bayer's animal

  • The human perspective The human perspective

    The latter deal will see Boehringer hand its consumer health interests to Sanofi in return for the French pharma firm's animal health arm Merial.

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

  • Pfizer names Albert Bourla as COO Pfizer names Albert Bourla as COO

    He has held several positions at Pfizer including general manager of the company’s established products business unit and area president for its animal health business across the EMEA regions. ... Pfizer has also promoted John Young, current group

  • Bayer appoints head of EU liaison office Bayer appoints head of EU liaison office

    Prior to his role at the IVA, Halling was responsible for communications and public relations at the International Federation for Animal Health.

  • Dr George Gunn moves from Novartis to join Nuritas Dr George Gunn moves from Novartis to join Nuritas

    Dr Gunn joins from Novartis where he acted as head of the company's animal health division and as a member of its global executive committee from 2004 until early last ... year. Prior to this, he also served as division head for consumer health and head

  • Merck KGaA 'to promote' Stefan Oschmann to chief executive Merck KGaA 'to promote' Stefan Oschmann to chief executive

    Prior to joining MSD Oschmann worked for the International Atomic Energy Agency IAEA from 1985 to 1987 and for the German Animal Health Federation (BfT) from 1987 to 1989.

  • Merck KGaA’s Oschmann elected president of IFPMA Merck KGaA’s Oschmann elected president of IFPMA

    Oschmann has worked in life sciences for several decades, including roles early in his career at the German Animal Health Federation and the German Chemical Industry Association. ... Oschmann said he was honoured to take over the role at an important

More from appointments
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 21 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...

Quick links